Research-Grade Ipamorelin Overview
Ipamorelin is a selective growth hormone secretagogue pentapeptide extensively investigated in preclinical research models. This synthetic compound, with CAS number 170851-70-4 and molecular weight 711.85 g/mol, functions as a selective ghrelin receptor agonist in laboratory studies. Researchers at Stroid UK Shop have demonstrated its unique properties in stimulating growth hormone release without significantly affecting cortisol or prolactin levels in experimental models.
The mechanism of action involves binding to ghrelin receptors, specifically the growth hormone secretagogue receptor type 1a (GHSR-1a), leading to increased growth hormone secretion through the hypothalamic-pituitary axis. This selectivity distinguishes ipamorelin from other growth hormone releasing compounds in comparative studies. Phase II clinical investigations have evaluated its therapeutic potential for post-surgical ileus, providing valuable data for peptide research applications.
Laboratory Research Applications
Ipamorelin serves multiple research purposes in endocrinology and peptide biology laboratories. Primary applications include investigating growth hormone axis modulation, examining selective ghrelin receptor activation, and studying peptide-based therapeutic mechanisms. Research teams analyse its effects on circadian rhythm patterns of growth hormone release, comparing it to natural ghrelin and other growth hormone secretagogues. The compound’s selectivity profile makes it particularly valuable for studies requiring precise hormonal pathway investigation without confounding variables from cortisol or prolactin elevation.
Additional research applications encompass metabolic studies, where scientists examine its influence on glucose homeostasis and energy expenditure in controlled laboratory environments. Studies within the broader ipamorelin research category demonstrate its utility in understanding peptide stability, receptor binding kinetics, and dose-response relationships in various experimental models.
Product Specifications
| Parameter | Specification |
|---|---|
| Purity | ≥98% (HPLC verified) |
| Molecular Formula | C₃₈H₄₉N₉O₅ |
| CAS Number | 170851-70-4 |
| Molecular Weight | 711.85 g/mol |
| Storage Temperature | -20°C (lyophilised) |
| Solubility | Water, DMSO |
| Appearance | White lyophilised powder |
| Vial Size | 2mg per vial |
Each vial contains precisely measured 2mg quantities suitable for accurate research protocols. The lyophilised formulation ensures extended stability when stored under appropriate laboratory conditions. Quality assurance documentation accompanies each batch, providing researchers with comprehensive analytical data for their studies. Storage recommendations include maintaining frozen conditions until reconstitution, with reconstituted solutions requiring refrigeration and usage within recommended timeframes for optimal research outcomes.
Research Compliance Notice
This ipamorelin preparation is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must ensure compliance with institutional guidelines and relevant regulations governing peptide research compounds. The product is supplied to qualified research institutions and individual researchers conducting legitimate scientific investigations into growth hormone secretagogues and related research compounds. Proper laboratory safety protocols, including appropriate handling procedures and waste disposal methods, must be followed during all research activities involving this compound.
